SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways pending completion of the COMP360 NDA submission is the main focus, with traders parsing the CEOs cautious go slow before we go fast comments as possible uncertainty around regulatory timing. The selloff is also attributed by some to broader biotech weakness, while others argue the companys Q4 submission plans remain intact.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Goldman Sachs upgrade to Buy and a wave of higher analyst targets have fueled attention around Zetas recent rally, alongside enthusiasm for its AI marketing platform and Palantir partnership. Traders are debating the sharp pullback despite that positive coverage, attributing it variously to options-expiration effects, profit-taking, and broader market weakness while others remain bullish on the companys growth story.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 2026 Phase 3 topline results for HLP003, its investigational treatment for major depressive disorder. Traders are divided between optimism that the results will confirm promising Phase 2 findings and concern about the binary trial risk, while also debating funding and dilution needs.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULF is caught in a broader AI-infrastructure selloff, with traders focused on inflation and interest-rate worries, financing costs, leverage, and doubts about the economics of data-center buildouts. Some argue its power-and-facilities leasing model and contracted AI/HPC business set it apart, and point to CEO comments and Morgan Stanleys bullish view as reasons for a high-volume rebound; others see the move as temporary and remain concerned about execution and funding.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

Rising oil and jet-fuel costs amid Middle East conflict dominate discussion, with traders concerned about pressure on American Airlines margins, earnings and debt burden. Some see a potential rebound if fuel costs ease, while others remain bearish on the cost outlook and the companys financial position.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

LRCX is under pressure amid a broader semiconductor-equipment pullback and concerns about AI investment and wafer-fab spending, with traders also focused on the companys upcoming earnings and guidance. Some see the selloff as an oversold buying opportunity, while others remain wary of sector weakness and further downside.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petrobras is drawing attention after reaching new 52-week highs amid a broad rally in Brazilian equities tied to Bolsonaros stronger-than-expected first-round showing; traders are also citing elevated oil prices, production growth and dividend potential. Optimism is tempered by concerns that oil could pull back, election uncertainty remains, and the stock may be vulnerable to profit-taking.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of Americas quarterly results missed expectations as a major regulatory penalty tied to anti-money-laundering and sanctions-compliance failures weighed on the report, driving a sharp selloff. Traders are debating whether the penalty is a one-off that makes the drop an opportunity or whether weaker trading and investment-banking performance point to further pressure.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Globals agreements with GE Vernova and Baker Hughes to support potential off-grid power for data centers have drawn attention as a possible expansion beyond LNG. Bulls see a new growth opportunity, while skeptics note that customer commitments and orders are still needed and question the future spending; insider sales and LNG-related risks also weigh on sentiment.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad concerns about a market correction, with traders pointing to rising bond yields and inflation, energy and geopolitical risks, and stretched AI-related valuations. Others favor VTI as a diversified, low-cost long-term holding and advocate continuing to buy through volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of...

Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before...

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market 

Equity

The plan would apparently temporarily allow specialty pharmacies to compound certain unapproved peptides, including BPC-157.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action...

HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline

HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026...

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.72, denoting a -6.7% move from the preceding trading day.

Hims & Hers Expands Australian Women's Health Platform With Hers

HIMS expands into Australia's women's healthcare market with the Hers launch, offering personalized treatments for weight, hormonal health and hair regrowth.

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein ImmediatelyPR NewswireNEW YORK, Oct. 14...

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 9, 2026. The company will host a live conference call to discuss the results at...

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Neutral Sentiment

Favorable

Unfavorable

Delayed

Hims & Hers ($HIMS) is bracing for a pivotal FDA advisory meeting on July 23-24 that will decide whether seven peptides get added to the compounding list. How do you think the FDA rules? Vote and explain your reasoning in the comments.

The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?

Stocktwits

Hims & Hers Health Inc

The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for 

Current Price	$28.07
Prev Close	$29.38
Open	$29.51
Dividend Yield	0.00%
50-Day Moving Average	$29.32
Beta	2.36
Avg. Volume	9.57M
PE Ratio	-45.06

52-Week High	$52.41
52-Week Low	$13.74
Market Capitalization	$6.85B
EPS (Annual)	$0.5123
Price to Book	20.21
Revenue Per Employee	$961,358.31

Feed

News

Sentiment

Earnings

Fundamentals

Info

HIMS Fundamentals